Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
18.38B | 19.85B | 21.66B | 18.26B | 14.78B | Gross Profit |
18.38B | 14.55B | 13.04B | 12.16B | 12.40B | EBIT |
4.93B | 4.47B | 4.88B | 4.37B | 2.90B | EBITDA |
7.17B | 6.83B | 6.91B | 6.27B | 3.89B | Net Income Common Stockholders |
2.90B | 2.29B | 7.80B | 2.35B | 1.64B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.93B | 4.25B | 2.77B | 3.35B | 2.50B | Total Assets |
106.74B | 98.33B | 92.70B | 94.86B | 67.22B | Total Debt |
48.36B | 47.07B | 42.98B | 45.47B | 31.22B | Net Debt |
47.18B | 46.52B | 42.82B | 45.26B | 31.06B | Total Liabilities |
68.92B | 68.43B | 63.13B | 71.00B | 47.36B | Stockholders Equity |
37.80B | 29.87B | 29.54B | 23.83B | 19.84B |
Cash Flow | Free Cash Flow | |||
-1.97B | -514.00M | 6.00M | 728.00M | -327.00M | Operating Cash Flow |
6.81B | 6.94B | 6.90B | 6.27B | 4.46B | Investing Cash Flow |
-10.57B | -7.50B | 240.00M | -14.01B | -5.12B | Financing Cash Flow |
4.53B | 987.00M | -7.17B | 7.77B | 750.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | £7.90B | 6.38 | 32.10% | 1.81% | -24.74% | -63.34% | |
73 Outperform | £51.30B | 16.97 | 8.35% | 5.83% | -7.42% | 5.84% | |
71 Outperform | £8.18B | 35.53 | 12.73% | 5.35% | 5.38% | 86.34% | |
71 Outperform | £19.77B | 16.61 | 12.29% | 2.33% | -13.09% | 231.40% | |
64 Neutral | $8.62B | 10.39 | 4.24% | 4.63% | 4.07% | -13.04% | |
£145.16M | 1.23 | 6.20% | ― | ― | |||
64 Neutral | £7.99B | 30.02 | 13.05% | 2.95% | 8.61% | ― |